157 related articles for article (PubMed ID: 18415771)
1. Intravenous cyclophosphamide in patients with chronic systemic inflammatory diseases: morbidity and mortality.
Gøransson LG; Brodin C; Ogreid P; Janssen EA; Romundstad PR; Vatten L; Wildhagen K; Kjellevold K; Omdal R
Scand J Rheumatol; 2008; 37(2):130-4. PubMed ID: 18415771
[TBL] [Abstract][Full Text] [Related]
2. Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: a data-driven review.
Monach PA; Arnold LM; Merkel PA
Arthritis Rheum; 2010 Jan; 62(1):9-21. PubMed ID: 20039416
[No Abstract] [Full Text] [Related]
3. Incidence of Cyclophosphamide-induced Urotoxicity and Protective Effect of Mesna in Rheumatic Diseases.
Yilmaz N; Emmungil H; Gucenmez S; Ozen G; Yildiz F; Balkarli A; Kimyon G; Coskun BN; Dogan I; Pamuk ON; Yasar S; Cetin GY; Yazici A; Ergulu Esmen S; Cagatay Y; Yilmaz S; Cefle A; Sayarlioglu M; Kasifoglu T; Karadag O; Pehlivan Y; Dalkilic E; Kisacik B; Cobankara V; Erken E; Direskeneli H; Aksu K; Yavuz S
J Rheumatol; 2015 Sep; 42(9):1661-6. PubMed ID: 26178288
[TBL] [Abstract][Full Text] [Related]
4. Malignancies in Wegener's granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients.
Faurschou M; Sorensen IJ; Mellemkjaer L; Loft AG; Thomsen BS; Tvede N; Baslund B
J Rheumatol; 2008 Jan; 35(1):100-5. PubMed ID: 17937462
[TBL] [Abstract][Full Text] [Related]
5. Urinary elimination of cyclophosphamide alkylating metabolites and free thiols following two administration schedules of high-dose cyclophosphamide and mesna.
Fleming RA; Cruz JM; Webb CD; Kucera GL; Perry JJ; Hurd DD
Bone Marrow Transplant; 1996 Apr; 17(4):497-501. PubMed ID: 8722345
[TBL] [Abstract][Full Text] [Related]
6. Mesna and furosemide for prevention of cyclophosphamide-induced sterile haemorrhagic cystitis in dogs--a retrospective study.
Laberke S; Zenker I; Hirschberger J
Vet Rec; 2014 Mar; 174(10):250. PubMed ID: 24463993
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy.
Mok CC; Lau CS; Wong RW
Arthritis Rheum; 1998 May; 41(5):831-7. PubMed ID: 9588734
[TBL] [Abstract][Full Text] [Related]
8. Prevention of further cyclophosphamide induced hemorrhagic cystitis by hyperbaric oxygen and mesna in guinea pigs.
Korkmaz A; Oter S; Deveci S; Goksoy C; Bilgic H
J Urol; 2001 Sep; 166(3):1119-23. PubMed ID: 11490309
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic strategy combining intravenous cyclophosphamide followed by oral azathioprine to treat worsening interstitial lung disease associated with systemic sclerosis: a retrospective multicenter open-label study.
Bérezné A; Ranque B; Valeyre D; Brauner M; Allanore Y; Launay D; Le Guern V; Kahn JE; Couderc LJ; Constans J; Cohen P; Mahr A; Pagnoux C; Hachulla E; Kahan A; Cabane J; Guillevin L; Mouthon L
J Rheumatol; 2008 Jun; 35(6):1064-72. PubMed ID: 18464307
[TBL] [Abstract][Full Text] [Related]
10. Carcinoma of the urinary bladder in patients receiving cyclophosphamide.
Wall RL; Clausen KP
N Engl J Med; 1975 Aug; 293(6):271-3. PubMed ID: 1138180
[TBL] [Abstract][Full Text] [Related]
11. Contribution of flavonoid antioxidants to the preventive effect of mesna in cyclophosphamide-induced cystitis in rats.
Ozcan A; Korkmaz A; Oter S; Coskun O
Arch Toxicol; 2005 Aug; 79(8):461-5. PubMed ID: 15800758
[TBL] [Abstract][Full Text] [Related]
12. Position statement of the Brazilian society of Rheumatology on mesna use as a preventive therapy for bladder disease in patients with systemic autoimmune diseases and systemic vasculitis under cyclophosphamide treatment.
Souza AWS; Dantas JG; Montandon ACOES; Calich AL; Mont' Alverne ARS; Gasparin AA; Bianchi D; Yuki EFN; Sacilotto N; Dos Reis Neto ET; Monticielo OA; Pereira IA
Adv Rheumatol; 2024 May; 64(1):41. PubMed ID: 38773538
[TBL] [Abstract][Full Text] [Related]
13. Incidence of hemorrhagic cystitis after cyclophosphamide therapy with or without mesna: A cohort study and comprehensive literature review.
Almalag HM; Alasmari SS; Alrayes MH; Binhameed MA; Alsudairi RA; Alosaimi MM; Alnasser GA; Abuzaid RA; Khalil N; Abouzaid HH; Alarfaj AS
J Oncol Pharm Pract; 2021 Mar; 27(2):340-349. PubMed ID: 32356687
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of the benefits of sodium 2-mercaptoethane sulfonate (MESNA) therapy for children undergoing high-dose chemotherapy].
Sato J; Takaue Y; Saito S; Okamoto Y; Hirao A; Shimizu T; Abe T; Watanabe T; Kawano Y; Ninomiya T
Rinsho Ketsueki; 1993 Jan; 34(1):7-12. PubMed ID: 8450612
[TBL] [Abstract][Full Text] [Related]
15. [Cancer of the bladder after cystitis due to cyclophosphamide. Apropos of a case].
Dore B; Grange P; Aubert J
J Urol (Paris); 1989; 95(7):427-31. PubMed ID: 2687398
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of antiphospholipid antibodies following cyclophosphamide therapy in patients with systemic lupus erythematosus.
Vlachoyiannopoulos PG; Toya SP; Katsifis G; Zintzaras E; Tzioufas AG; Moutsopoulos HM
J Rheumatol; 2008 Sep; 35(9):1768-75. PubMed ID: 18634157
[TBL] [Abstract][Full Text] [Related]
17. Cyclophosphamide-induced hemorrhagic cystitis in young patients with solid tumors: A single institution study.
Saito Y; Kumamoto T; Shiraiwa M; Sonoda T; Arakawa A; Hashimoto H; Tamai I; Ogawa C; Terakado H
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e460-e464. PubMed ID: 29989294
[TBL] [Abstract][Full Text] [Related]
18. Contribution of antioxidants to preventive effect of mesna in cyclophosphamide-induced hemorrhagic cystitis in rats.
Yildirim I; Korkmaz A; Oter S; Ozcan A; Oztas E
Cancer Chemother Pharmacol; 2004 Nov; 54(5):469-73. PubMed ID: 15232716
[TBL] [Abstract][Full Text] [Related]
19. [The occurrence of malignancies in a Hungarian lupus population].
Tarr T; Szekanecz E; Zeher M; Szegedi G; Kiss E
Orv Hetil; 2006 Nov; 147(46):2229-33. PubMed ID: 17396395
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of systemic diseases with pulse cyclophosphamide: 15 cases].
Amoura Z; Choukroun G; Royer I; Gayraud M; Guillevin L
Ann Med Interne (Paris); 1990; 141(5):416-20. PubMed ID: 2256584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
